Mutua Madrileña Foundation funds a research project on personalized treatments in lung cancer
The Mutua Madrileña Foundation in its XI Call for Research Grants, has selected a project aimed at personalizing the treatment of lung cancer led by the team leader of the ICO-IDIBELL chemoresistance group, Alberto Villanueva. The project is based on the personalization of cancer treatments for non-small cell lung (NSCLC) by the generation of mouse […]